Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05008224
Title Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) (KEYNOTE-C11)
Acronym KEYNOTE-C11
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
St Joseph Heritage Healthcare-Oncology ( Site 0004) Fullerton California 92835 United States Details
Stanford Cancer Center ( Site 0023) Palo Alto California 94304 United States Details
Northwestern Memorial Hospital ( Site 0002) Chicago Illinois 60611 United States Details
OptumCare Cancer Care-Research Department ( Site 0005) Las Vegas Nevada 89102 United States Details
University of Tennessee Medical Center-Cancer Institute ( Site 0006) Knoxville Tennessee 37920 United States Details
Texas Oncology-Plano East ( Site 0020) Plano Texas 75075 United States Details
Liverpool Hospital-Haematology ( Site 0906) Liverpool New South Wales 2170 Australia Details
Mater Misericordiae Limited ( Site 0904) Brisbane Queensland 4101 Australia Details
Princess Alexandra Hospital-Division of Cancer Services Trials Unit ( Site 0907) Woolloongabba Queensland 4102 Australia Details
Monash Health-Haematology Research ( Site 0908) Clayton Victoria 3168 Australia Details
Peter MacCallum Cancer Centre ( Site 0905) Melbourne Victoria 3000 Australia Details
Cross Cancer Institute ( Site 0207) Edmonton Alberta T6G 1Z2 Canada Details
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0205) Greenfield Park Quebec J4V 2H1 Canada Details
Jewish General Hospital ( Site 0200) Montreal Quebec H3T 1E2 Canada Details
Hopital du Sacre-Coeur de Montreal ( Site 0206) Montreal Quebec H4J 1C5 Canada Details
McGill University Health Centre ( Site 0209) Montréal Quebec H4A 3J1 Canada Details
Centro Investigación del Cáncer James Lind ( Site 1200) Temuco Araucania 4780000 Chile Details
Instituto Nacional del Cancer ( Site 1205) Chile Region M. De Santiago 8380455 Chile Details
FALP-UIDO ( Site 1202) Santiago Region M. De Santiago 6900941 Chile Details
Clínica Alemana de Santiago ( Site 1206) Santiago Region M. De Santiago 8320325 Chile Details
Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 1204) Santiago Region M. De Santiago 8330032 Chile Details
CHU Bordeaux Haut-Leveque ( Site 1505) Pessac Aquitaine 33600 France Details
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou-haematology ( Site 1502) Rennes Bretagne 35033 France Details
Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1504) Dijon Cote-d Or 21000 France Details
centre hospitalier lyon sud-Service Hématologie ( Site 1501) Pierre-Bénite Rhone 69310 France Details
Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen-Service d'Hématologie ( Si Rouen Seine-Maritime 76000 France Details
Rambam Health Care Campus ( Site 1907) Haifa 3109601 Israel Details
Bnai Zion Medical Center-Hematology ( Site 1909) Haifa 3339419 Israel Details
Hadassah Medical Center ( Site 1901) Jerusalem 9112001 Israel Details
Sheba Medical Center-Hemato Oncology ( Site 1904) Ramat Gan 5265601 Israel Details
ZIV Medical Center ( Site 1908) Safed 1311001 Israel Details
Sourasky Medical Center ( Site 1905) Tel Aviv 6423906 Israel Details
Azienda Ospedaliera Spedali Civili di Brescia-Hemathology ( Site 1801) Brescia Lombardia 25123 Italy Details
ASST Grande Ospedale Metropolitano Niguarda ( Site 1803) Milan Milano Italy Details
Policlinico S. Orsola- Malpighi-Istituto di Ematologia L. e A. Seragnoli ( Site 1800) Bologna 40138 Italy Details
Fondazione Policlinico Universitario Agostino Gemelli-ISTITUTO DI EMATOLOGIA ( Site 1804) Roma 00168 Italy Details
Klinika Hematologii - Instytut Hematologii i Transfuzjologii-Klinika Hematologii ( Site 0402) Warsaw Mazowieckie 02-776 Poland Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Warszawa Mazowieckie 02-781 Poland Details
Szpital Wojewódzki w Opolu-Hematology Department ( Site 0401) Opole Opolskie 46-020 Poland Details
Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 0403) Gdańsk Pomorskie 80-952 Poland Details
Moscow City Clinical Hospital S.P. Botkin ( Site 0702) Moscow Moskva 125284 Russian Federation Details
First Pavlov State Medical University of Saint Petersburg-Raisa Gorbacheva Memorial Institut for Pe Saint Petersburg Sankt-Peterburg 197022 Russian Federation Details
Almazov National Medical Research Centre ( Site 0704) Saint Petersburg Sankt-Peterburg 197341 Russian Federation Details
Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 1031) L'Hospitalet Del Llobregat Barcelona 08908 Spain Details
Hospital Universitario 12 de Octubre ( Site 1032) Madrid 28041 Spain Details
Dokuz Eylül Üniversitesi ( Site 5002) Balçova Izmir Turkey Details
Ankara University Hospital Cebeci-hematology ( Site 5000) Ankara 06100 Turkey Details
Vehbi Koc Vakfi - Amerikan Hastanesi ( Site 5001) Istanbul 34365 Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field